Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jennifer Kiser

Concepts (358)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
32
2025
712
6.310
 Why?
Anti-HIV Agents
35
2025
754
4.600
 Why?
HIV Infections
56
2025
2720
4.410
 Why?
Hepatitis C
13
2023
238
4.290
 Why?
Adenine
29
2025
256
4.220
 Why?
Hepatitis C, Chronic
14
2025
153
4.030
 Why?
Ribavirin
15
2020
91
3.810
 Why?
Sofosbuvir
13
2025
58
3.750
 Why?
Drug Interactions
21
2019
394
3.330
 Why?
Tenofovir
30
2025
231
3.300
 Why?
Tandem Mass Spectrometry
17
2025
524
2.320
 Why?
Hepacivirus
11
2025
235
2.000
 Why?
Dried Blood Spot Testing
13
2024
94
1.930
 Why?
Proline
5
2019
76
1.880
 Why?
Organophosphates
15
2025
120
1.800
 Why?
Oligopeptides
8
2015
257
1.790
 Why?
Emtricitabine
19
2025
168
1.760
 Why?
Organophosphonates
12
2014
92
1.580
 Why?
Ritonavir
8
2021
73
1.460
 Why?
Protease Inhibitors
4
2020
106
1.410
 Why?
Coinfection
5
2024
131
1.320
 Why?
Chromatography, Liquid
14
2025
423
1.320
 Why?
Benzimidazoles
6
2025
162
1.240
 Why?
Phosphorous Acids
3
2019
13
1.210
 Why?
Fluorenes
4
2020
40
1.110
 Why?
Pyrophosphatases
3
2016
22
1.090
 Why?
Hepatitis B
4
2024
63
1.080
 Why?
Nucleotides
3
2016
122
1.070
 Why?
Medication Adherence
16
2022
558
0.970
 Why?
Anti-Retroviral Agents
5
2019
231
0.950
 Why?
Drug Therapy, Combination
12
2018
1040
0.870
 Why?
Pyridines
5
2015
478
0.850
 Why?
Humans
101
2025
129652
0.790
 Why?
Polyphosphates
7
2022
37
0.780
 Why?
Erythrocytes
8
2016
672
0.780
 Why?
Cell Phone
1
2022
70
0.760
 Why?
Reverse Transcriptase Inhibitors
5
2014
83
0.750
 Why?
HIV Protease Inhibitors
5
2011
68
0.750
 Why?
Viral Load
11
2024
448
0.730
 Why?
Membrane Transport Proteins
4
2016
149
0.730
 Why?
Simeprevir
2
2018
9
0.720
 Why?
HIV-1
7
2021
836
0.710
 Why?
Sulfonamides
5
2019
496
0.700
 Why?
Mobile Applications
1
2022
160
0.670
 Why?
Therapies, Investigational
1
2019
17
0.660
 Why?
Heterocyclic Compounds, 3-Ring
2
2023
31
0.630
 Why?
Respiratory Syncytial Virus Infections
1
2020
120
0.620
 Why?
Adult
45
2025
35577
0.610
 Why?
Leukocytes, Mononuclear
9
2025
545
0.600
 Why?
Male
55
2025
63682
0.600
 Why?
Ethanol
1
2023
589
0.600
 Why?
Middle Aged
39
2025
31155
0.590
 Why?
Pyridazines
2
2021
54
0.580
 Why?
Antiretroviral Therapy, Highly Active
4
2015
267
0.580
 Why?
Lung Transplantation
1
2020
289
0.570
 Why?
Solid Phase Extraction
2
2014
23
0.560
 Why?
Pyrimidinones
2
2008
103
0.540
 Why?
Liver
2
2016
1839
0.540
 Why?
HIV Integrase Inhibitors
1
2018
69
0.530
 Why?
Inosine
1
2016
13
0.530
 Why?
Guanosine
1
2016
42
0.520
 Why?
Pharmacogenomic Variants
1
2016
35
0.520
 Why?
Female
50
2025
68777
0.500
 Why?
Purines
1
2016
172
0.490
 Why?
Carbamates
2
2025
46
0.480
 Why?
Chromatography, High Pressure Liquid
2
2015
582
0.480
 Why?
Drug Discovery
1
2016
131
0.480
 Why?
Drug Monitoring
3
2022
216
0.480
 Why?
Isoniazid
2
2012
63
0.470
 Why?
Serum
1
2015
58
0.470
 Why?
Adenosine
1
2016
227
0.460
 Why?
Kidney
4
2016
1385
0.460
 Why?
Intracellular Space
1
2014
69
0.460
 Why?
Pre-Exposure Prophylaxis
5
2020
203
0.440
 Why?
Telemedicine
1
2022
788
0.440
 Why?
HIV
4
2019
226
0.440
 Why?
Receptors, Adrenergic, alpha
1
2013
31
0.430
 Why?
Priapism
1
2013
11
0.430
 Why?
Adrenergic alpha-Antagonists
1
2013
33
0.430
 Why?
Deoxycytidine
6
2017
165
0.430
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.430
 Why?
Antitubercular Agents
2
2012
200
0.430
 Why?
Hepatitis B, Chronic
3
2022
18
0.400
 Why?
Hepatitis B virus
4
2024
35
0.400
 Why?
Treatment Outcome
13
2025
10230
0.400
 Why?
Gastric Bypass
1
2014
107
0.390
 Why?
Alanine
5
2025
142
0.360
 Why?
Prospective Studies
17
2022
7133
0.360
 Why?
Phenotype
2
2016
3076
0.360
 Why?
HIV Seronegativity
1
2010
25
0.350
 Why?
Antacids
1
2010
16
0.350
 Why?
Pyrrolidinones
1
2010
29
0.350
 Why?
Genotype
6
2023
1839
0.350
 Why?
Pyrimidines
3
2021
459
0.340
 Why?
Patient Compliance
3
2017
565
0.340
 Why?
Tuberculosis
2
2012
272
0.330
 Why?
Pharmacy Service, Hospital
1
2011
90
0.330
 Why?
Pregnancy Complications, Infectious
3
2025
367
0.330
 Why?
Blood Chemical Analysis
4
2019
96
0.330
 Why?
Plasma
4
2016
206
0.320
 Why?
Reproducibility of Results
8
2016
3083
0.320
 Why?
Area Under Curve
4
2018
304
0.320
 Why?
Uridine Monophosphate
2
2019
15
0.310
 Why?
Drug Prescriptions
1
2011
248
0.310
 Why?
Young Adult
17
2025
12427
0.300
 Why?
Fluorobenzenes
1
2008
15
0.300
 Why?
Adolescent
20
2020
20394
0.290
 Why?
Drug Stability
5
2016
159
0.290
 Why?
Guidelines as Topic
1
2009
264
0.280
 Why?
Atazanavir Sulfate
5
2015
41
0.270
 Why?
Liver Transplantation
1
2014
831
0.270
 Why?
Sensitivity and Specificity
5
2014
1838
0.270
 Why?
Half-Life
3
2015
162
0.260
 Why?
Esomeprazole
1
2006
6
0.260
 Why?
Anti-Ulcer Agents
1
2006
15
0.260
 Why?
Glycerophospholipids
2
2023
34
0.260
 Why?
Pharmacology, Clinical
1
2006
9
0.250
 Why?
Sustained Virologic Response
3
2023
37
0.250
 Why?
Hepatocytes
3
2016
216
0.250
 Why?
Education
1
2006
101
0.240
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2025
19
0.240
 Why?
Proton Pump Inhibitors
1
2006
100
0.240
 Why?
South Africa
4
2015
192
0.230
 Why?
Phosphates
3
2015
180
0.220
 Why?
Anemia
2
2016
160
0.220
 Why?
Biomarkers
5
2023
3973
0.220
 Why?
Health Personnel
1
2009
652
0.210
 Why?
Variola virus
1
2022
1
0.210
 Why?
Smallpox
1
2022
8
0.200
 Why?
World Health Organization
1
2022
110
0.200
 Why?
Delivery of Health Care
1
2009
894
0.190
 Why?
Blood Platelets
1
2025
380
0.190
 Why?
Linear Models
2
2014
819
0.190
 Why?
Cross-Over Studies
4
2020
521
0.190
 Why?
Cyclopropanes
2
2019
89
0.190
 Why?
Lopinavir
3
2020
30
0.180
 Why?
Point-of-Care Systems
1
2023
147
0.180
 Why?
Dideoxynucleosides
2
2023
20
0.180
 Why?
Phosphorylation
2
2015
1713
0.170
 Why?
Interferons
2
2019
194
0.170
 Why?
Aminoisobutyric Acids
1
2019
7
0.170
 Why?
Drug Administration Schedule
3
2019
769
0.170
 Why?
Neutrophils
1
2025
1205
0.160
 Why?
Lactams, Macrocyclic
1
2019
49
0.160
 Why?
Homosexuality, Male
2
2017
175
0.160
 Why?
Pyrrolidines
1
2019
67
0.160
 Why?
Quinoxalines
1
2019
65
0.160
 Why?
Leucine
1
2019
108
0.160
 Why?
Nucleic Acids
1
2019
60
0.160
 Why?
Quality Control
2
2015
163
0.150
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.150
 Why?
Oxazines
1
2018
28
0.140
 Why?
Multidrug Resistance-Associated Proteins
2
2008
37
0.140
 Why?
Directly Observed Therapy
1
2017
15
0.140
 Why?
Bronchoalveolar Lavage Fluid
1
2020
644
0.140
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2017
17
0.140
 Why?
Liver Cirrhosis
1
2019
280
0.140
 Why?
Nitriles
2
2021
172
0.140
 Why?
Pregnancy Outcome
1
2020
390
0.140
 Why?
Inosine Triphosphate
1
2016
3
0.140
 Why?
Pharmacogenetics
2
2016
175
0.140
 Why?
Anemia, Hemolytic
1
2016
16
0.140
 Why?
Darunavir
2
2014
18
0.130
 Why?
Deoxyadenine Nucleotides
1
2016
13
0.130
 Why?
Deoxycytosine Nucleotides
1
2016
11
0.130
 Why?
Drug Combinations
3
2025
330
0.130
 Why?
Guanosine Triphosphate
1
2016
92
0.130
 Why?
Glass
1
2016
42
0.130
 Why?
Molecular Targeted Therapy
1
2019
390
0.130
 Why?
Pharmacy
1
2017
31
0.130
 Why?
Genitalia
1
2016
30
0.130
 Why?
Disease Transmission, Infectious
1
2017
55
0.130
 Why?
Syringes
1
2016
43
0.130
 Why?
Drug Packaging
1
2016
41
0.130
 Why?
Drug and Narcotic Control
1
2016
28
0.130
 Why?
Pyridones
1
2018
159
0.130
 Why?
Viremia
3
2022
131
0.130
 Why?
Zika Virus
1
2017
118
0.130
 Why?
Fibroblast Growth Factors
2
2014
170
0.120
 Why?
Polymers
1
2019
479
0.120
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2011
430
0.120
 Why?
Retrospective Studies
4
2020
14518
0.120
 Why?
Practice Guidelines as Topic
2
2016
1501
0.120
 Why?
Biological Assay
1
2016
118
0.120
 Why?
Analgesics
1
2017
189
0.120
 Why?
Cytosol
1
2016
218
0.120
 Why?
Polymorphism, Single Nucleotide
2
2016
2073
0.120
 Why?
Piperazines
1
2018
342
0.120
 Why?
Rectum
1
2016
170
0.120
 Why?
Creatinine
2
2018
491
0.120
 Why?
Brain Diseases
1
2016
137
0.120
 Why?
Population
1
2015
34
0.120
 Why?
Chemical and Drug Induced Liver Injury
1
2016
132
0.120
 Why?
Nonlinear Dynamics
1
2015
89
0.120
 Why?
Mental Health Services
1
2019
404
0.120
 Why?
Virus Replication
1
2017
451
0.120
 Why?
Liver Function Tests
1
2015
112
0.120
 Why?
CD4 Lymphocyte Count
2
2015
266
0.110
 Why?
Pharmacists
1
2017
247
0.110
 Why?
Infectious Disease Transmission, Vertical
3
2025
170
0.110
 Why?
Pharmaceutical Preparations
1
2016
171
0.110
 Why?
Administration, Oral
3
2019
786
0.110
 Why?
Adenosine Triphosphate
1
2016
480
0.110
 Why?
Least-Squares Analysis
1
2014
78
0.110
 Why?
Infant
5
2020
9024
0.110
 Why?
Metabolic Clearance Rate
2
2018
118
0.110
 Why?
Cholecalciferol
1
2014
56
0.110
 Why?
Hypophosphatemia
1
2013
17
0.110
 Why?
Double-Blind Method
3
2013
1876
0.110
 Why?
Liver Diseases
1
2016
290
0.110
 Why?
Diphosphates
3
2021
17
0.100
 Why?
Calcitriol
1
2013
55
0.100
 Why?
Tablets
2
2023
36
0.100
 Why?
Cytochrome P-450 CYP3A
1
2013
87
0.100
 Why?
Leukocytes
1
2014
304
0.100
 Why?
Desiccation
1
2012
20
0.100
 Why?
Monocytes
1
2015
551
0.100
 Why?
Case-Control Studies
3
2024
3381
0.100
 Why?
Kidney Diseases
1
2016
384
0.100
 Why?
Diabetes Mellitus
1
2020
1001
0.100
 Why?
Benzoxazines
1
2012
30
0.100
 Why?
Organic Anion Transporters
1
2011
16
0.100
 Why?
Levonorgestrel
1
2012
37
0.090
 Why?
Pravastatin
1
2011
40
0.090
 Why?
Child, Preschool
4
2021
10517
0.090
 Why?
Arylamine N-Acetyltransferase
1
2011
5
0.090
 Why?
Vitamin D Deficiency
1
2013
176
0.090
 Why?
Benchmarking
2
2024
176
0.090
 Why?
Nucleosides
1
2011
27
0.090
 Why?
Interferon-alpha
1
2012
194
0.090
 Why?
Specimen Handling
1
2012
164
0.090
 Why?
Mental Disorders
1
2019
1030
0.090
 Why?
Contraceptive Agents, Female
1
2012
78
0.090
 Why?
Models, Statistical
1
2015
623
0.090
 Why?
Raltegravir Potassium
1
2010
17
0.090
 Why?
Body Weight
1
2015
940
0.090
 Why?
Hospitals, University
1
2011
179
0.090
 Why?
Patient Acceptance of Health Care
1
2017
759
0.090
 Why?
Sex Distribution
1
2011
359
0.080
 Why?
Cohort Studies
2
2019
5420
0.080
 Why?
Aged
5
2018
22104
0.080
 Why?
Sex Characteristics
1
2015
737
0.080
 Why?
Dietary Supplements
1
2014
534
0.080
 Why?
Mycobacterium tuberculosis
1
2012
308
0.080
 Why?
Time Factors
4
2016
6556
0.080
 Why?
Lamivudine
2
2023
61
0.070
 Why?
Rosuvastatin Calcium
1
2008
20
0.070
 Why?
Pregnancy
4
2025
6402
0.070
 Why?
Immunosuppressive Agents
1
2012
853
0.070
 Why?
Kidney Calculi
1
2007
35
0.070
 Why?
Portugal
1
2006
10
0.070
 Why?
Gene Frequency
1
2008
503
0.070
 Why?
Education, Medical
1
2009
244
0.060
 Why?
Quebec
1
2006
10
0.060
 Why?
Furans
1
2006
23
0.060
 Why?
Self Report
2
2021
799
0.060
 Why?
Dementia
1
2009
227
0.060
 Why?
Referral and Consultation
1
2011
733
0.060
 Why?
Benzopyrans
1
2025
31
0.060
 Why?
Internationality
1
2006
149
0.060
 Why?
Sexual and Gender Minorities
2
2019
194
0.060
 Why?
United States
4
2017
13903
0.060
 Why?
Hematocrit
2
2016
93
0.060
 Why?
Child
4
2021
20883
0.060
 Why?
Lipids
1
2008
625
0.060
 Why?
Predictive Value of Tests
2
2019
1952
0.050
 Why?
Isoindoles
1
2022
4
0.050
 Why?
Monkeypox virus
1
2022
13
0.050
 Why?
Risk Assessment
1
2012
3240
0.050
 Why?
Calibration
2
2013
140
0.050
 Why?
Demography
1
2022
279
0.050
 Why?
Benzamides
1
2022
207
0.050
 Why?
Treatment Failure
1
2023
340
0.050
 Why?
Computer Simulation
2
2016
943
0.050
 Why?
Animals
4
2022
35361
0.050
 Why?
Temperature
2
2016
636
0.050
 Why?
Drug Approval
1
2020
88
0.040
 Why?
Tissue Donors
1
2023
391
0.040
 Why?
Lactation
1
2020
170
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
2012
0.040
 Why?
Models, Biological
2
2016
1722
0.040
 Why?
Developing Countries
1
2020
287
0.040
 Why?
Chemistry Techniques, Analytical
1
2018
19
0.040
 Why?
Flaviviridae
1
2017
5
0.040
 Why?
Vero Cells
1
2017
65
0.040
 Why?
Drug Repositioning
1
2017
25
0.040
 Why?
A549 Cells
1
2017
59
0.040
 Why?
Inhibitory Concentration 50
1
2017
86
0.040
 Why?
Hair
1
2018
73
0.040
 Why?
Pharmaceutical Solutions
1
2016
14
0.030
 Why?
Patient Selection
1
2020
663
0.030
 Why?
Breast Feeding
1
2020
424
0.030
 Why?
Chromatography, Reverse-Phase
1
2016
27
0.030
 Why?
Drug Storage
1
2016
57
0.030
 Why?
Cities
1
2017
105
0.030
 Why?
Defective Viruses
1
2016
5
0.030
 Why?
Acute Disease
1
2019
980
0.030
 Why?
Alcohol Drinking
1
2023
764
0.030
 Why?
Drug Compounding
1
2016
97
0.030
 Why?
Solubility
1
2016
235
0.030
 Why?
Methanol
1
2016
35
0.030
 Why?
Spermatozoa
1
2016
91
0.030
 Why?
Clinical Trials as Topic
1
2020
1004
0.030
 Why?
Solutions
1
2016
151
0.030
 Why?
Cold Temperature
1
2016
155
0.030
 Why?
Hydrogen-Ion Concentration
1
2016
544
0.030
 Why?
Blood-Brain Barrier
1
2016
132
0.030
 Why?
Pregnancy Complications
1
2020
493
0.030
 Why?
Administration, Inhalation
1
2016
666
0.030
 Why?
Comorbidity
1
2019
1547
0.030
 Why?
Logistic Models
1
2020
1988
0.030
 Why?
Risk-Taking
1
2017
347
0.030
 Why?
Interleukins
1
2016
241
0.030
 Why?
DNA, Viral
1
2016
350
0.030
 Why?
Recurrence
1
2017
1007
0.030
 Why?
Feasibility Studies
1
2017
868
0.030
 Why?
Vitamin D-Binding Protein
1
2013
15
0.030
 Why?
Mental Health
1
2019
686
0.030
 Why?
Algorithms
1
2020
1622
0.030
 Why?
Parathyroid Hormone
1
2013
106
0.030
 Why?
Water
1
2016
448
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
253
0.020
 Why?
Therapeutic Equivalency
1
2012
30
0.020
 Why?
Alkynes
1
2012
55
0.020
 Why?
Cell Line
1
2017
2781
0.020
 Why?
Anion Exchange Resins
1
2011
7
0.020
 Why?
Zidovudine
1
2011
78
0.020
 Why?
Food-Drug Interactions
1
2010
9
0.020
 Why?
Reference Standards
1
2011
177
0.020
 Why?
Longitudinal Studies
1
2018
2717
0.020
 Why?
Chemoprevention
1
2010
91
0.020
 Why?
Latent Tuberculosis
1
2011
67
0.020
 Why?
Epithelial Cells
1
2016
1065
0.020
 Why?
Haplotypes
1
2011
475
0.020
 Why?
Cholesterol
1
2011
412
0.020
 Why?
Glomerular Filtration Rate
1
2013
711
0.020
 Why?
Triglycerides
1
2011
527
0.020
 Why?
AIDS Dementia Complex
1
2009
51
0.020
 Why?
Infant, Newborn
1
2020
5762
0.020
 Why?
Polymorphism, Genetic
1
2011
640
0.020
 Why?
Follow-Up Studies
1
2017
4897
0.020
 Why?
Cross-Sectional Studies
1
2019
5066
0.020
 Why?
Acquired Immunodeficiency Syndrome
1
2009
227
0.020
 Why?
Positron-Emission Tomography
1
2009
288
0.020
 Why?
Antiemetics
1
1987
41
0.020
 Why?
Calcium
1
2013
1213
0.020
 Why?
Vomiting
1
1987
128
0.020
 Why?
Gene Expression Regulation
1
2016
2548
0.020
 Why?
Aged, 80 and over
1
2018
7086
0.020
 Why?
Neuropsychological Tests
1
2009
1015
0.010
 Why?
Brain
1
2016
2679
0.010
 Why?
Age Factors
1
2011
3144
0.010
 Why?
Alzheimer Disease
1
2009
519
0.010
 Why?
Magnetic Resonance Imaging
1
2009
3408
0.010
 Why?
Antineoplastic Agents
1
1987
2061
0.010
 Why?
Flunitrazepam
1
1987
3
0.000
 Why?
Metoclopramide
1
1987
19
0.000
 Why?
Methylprednisolone
1
1987
83
0.000
 Why?
Kiser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (358) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)